|
Market Closed -
Nasdaq
06:00:00 19/09/26 am AEST
|
5-day change | 1st Jan Change | ||
| 4.110 USD | -0.96% |
|
-13.66% | -64.72% |
| 14/08 | ARS Pharmaceuticals Q2 Net Loss Widens, Revenue Rises | MT |
| 14/08 | ARS Pharmaceuticals, Inc., Q2 2026 Earnings Call, Aug 13, 2026 |
Chart: Technical Analysis
NasdaqUSD
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| SPRY | Delayed | |
CBOE
| SPRY | Real-time |
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bearish | Bearish | Bearish |
| Resistance | 5.35 | 6.38 | 7.425 |
| Spread/Res. | -23.18% | -35.58% | -44.65% |
| Spread/Supp. | +9.02% | +9.02% | +18.44% |
| Support | 3.77 | 3.77 | 3.47 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- SPRY Stock
- Charts ARS Pharmaceuticals, Inc.
Select your edition
All financial news and data tailored to specific country editions
